At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 5, 2026 at 06:39 ET
Three C-suite insiders at Nurix Therapeutics (CSO, CLO, CFO) sold a total of $461K in open-market shares over a 7-day window, representing just 0.02% of the $2.4B market cap. The sales are trivial in size and appear liquidity-driven following option exercises, providing no material signal about the company's outlook.
- Total open-market insider sales: $461,000 across 3 C-suite executives (CSO, CLO, CFO)
- Sales represent 0.02% of Nurix's $2.4B market cap, well below the 0.1% materiality threshold
- Multiple derivative exercises (non-cash) preceded the sales, consistent with routine option exercise and tax-covering or diversification
- Prior insider activity (30d) shows 6 sells totaling $665K, indicating ongoing but modest selling patterns
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access